Try our beta test site
64 studies found for:    antineoplaston
Show Display Options
RSS Create an RSS feed from your search for:
antineoplaston
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
Antineoplaston Therapy in Treating Patients With Meningioma
Condition: Meningioma
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
2 Completed
Has Results
Antineoplaston Therapy in Treating Children With Brain Tumors
Condition: Childhood Brain Tumors
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
3 Terminated
Has Results
Antineoplaston Therapy in Treating Patients With Ependymoma
Condition: Ependymoma
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
4 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: Refractory Brain Tumors
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
5 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Brain Stem Glioma
Condition: Brain Stem Gliomas
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
6 Completed
Has Results
Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma
Condition: Adult Brain Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
7 Completed
Has Results
Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
Condition: Low Grade Astrocytomas
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
8 Terminated Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma
Condition: CNS Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
9 Completed
Has Results
Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
Condition: Visual Pathway Glioma
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
10 Completed
Has Results
Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors
Condition: Childhood CNS Primitive Neuroectodermal Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
11 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma
Condition: Anaplastic Astrocytoma
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
12 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Condition: Malignant Brain Tumors
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
13 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
Condition: Mixed Gliomas
Interventions: Drug: Atengenal;   Drug: Astugenal
14 Not yet recruiting Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma
Condition: Brain Stem Glioma
Interventions: Radiation: Radiation;   Drug: Atengenal;   Drug: Astugenal
15 Not yet recruiting Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma
Condition: Brain Stem Glioma
Interventions: Radiation: Radiation;   Drug: Atengenal;   Drug: Astugenal
16 Unknown  Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Intervention: Drug: antineoplaston A10
17 Terminated Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
18 Unknown  Antineoplaston Therapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
19 Completed Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
20 Unknown  Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.